Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in France
France: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 93.0% in 2025. ◆ Volatile
Measles-containing-vaccine second-dose (MCV2) immunization coverage in France, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine second-dose (mcv2) immunization coverage in France is 93.0%, measured in 2025. That is the highest value across all 26 years on record.
Compared with earlier readings it is up 17.7% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in France peaked at 93.0% in 2022 and was at its lowest, 0.0%, in 2000.
France ranks 49th of 194 countries on this measure, in the top quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in France, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 0.0% | — |
| 2006 | 0.0% | — |
| 2007 | 0.0% | — |
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 61.0% | — |
| 2011 | 67.0% | +9.8% |
| 2012 | 72.0% | +7.5% |
| 2013 | 75.0% | +4.2% |
| 2014 | 77.0% | +2.7% |
| 2015 | 79.0% | +2.6% |
| 2016 | 80.0% | +1.3% |
| 2017 | 80.0% | +0.0% |
| 2018 | 83.0% | +3.8% |
| 2019 | 86.0% | +3.6% |
| 2020 | 91.0% | +5.8% |
| 2021 | 91.0% | +0.0% |
| 2022 | 93.0% | +2.2% |
| 2023 | 93.0% | +0.0% |
| 2024 | 93.0% | +0.0% |
| 2025 | 93.0% | +0.0% |
France compared with similar countries
- France's 93.0% is above the median for high income countries, which is 92.0%, 1.0× the median. (63 countries reporting)
- France's 93.0% is above the median for Europe & Central Asia, which is 90.0%, 1.0× the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 10 |
| 2010s | 76.0% | 61.0% | 86.0% | 10 |
| 2020s | 92.3% | 91.0% | 93.0% | 6 |
Countries ranked near France
More health data for France
- Un projection of annual infant deaths, annual growth rate -1.31 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0689 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,016 deaths per 1,000 people (2090)
- Number of infants who die before age 1 603 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -0.7875 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0244 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8291 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in France?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in France was 93.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in France?
- The highest recorded value was 93.0% in 2022.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in France?
- The lowest recorded value was 0.0% in 2000.
- How does France rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- France ranks 49th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in France?
- Over the last ten years it is up 17.7%. The long-run trend across the full record is volatile.
- Where does this France data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).